Your browser doesn't support javascript.
loading
Reply to 'Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?'
Shiti, Assad; Goldfracht, Idit; Shaheen, Naim; Protze, Stephanie; Gepstein, Lior.
Afiliação
  • Shiti A; Sohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine, the Rappaport Faculty of Medicine and Research Institute, Technion‒Israel Institute of Technology, Haifa, Israel.
  • Goldfracht I; Sohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine, the Rappaport Faculty of Medicine and Research Institute, Technion‒Israel Institute of Technology, Haifa, Israel.
  • Shaheen N; Sohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine, the Rappaport Faculty of Medicine and Research Institute, Technion‒Israel Institute of Technology, Haifa, Israel.
  • Protze S; McEwen Center for Regenerative Medicine, University Health Network, Toronto, ON, Canada.
  • Gepstein L; Sohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine, the Rappaport Faculty of Medicine and Research Institute, Technion‒Israel Institute of Technology, Haifa, Israel. mdlior@technion.ac.il.
Nat Commun ; 12(1): 1729, 2021 03 19.
Article em En | MEDLINE | ID: mdl-33741922

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Preparações Farmacêuticas / Células-Tronco Pluripotentes Induzidas Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Preparações Farmacêuticas / Células-Tronco Pluripotentes Induzidas Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel